Trevi Therapeutics TRVI
NASDAQ TRVI
$14.56 +0.24 (+1.71%)
As of: Oct 1, 2026 · 12:39 PM EDT

Trevi Therapeutics (TRVI) Other Non-Current Assets (2018 - 2026)

Updated

Trevi Therapeutics' Other Non-Current Assets came in at $3.94 million for Q2 2026, compared with $68,000 a year earlier and up 50.8% from the prior quarter.

Analysis

Trevi Therapeutics (TRVI) Other Non-Current Assets (2018 - 2026) Analysis & Trends

At the end of FY2025, Trevi Therapeutics' Other Non-Current Assets was $928,000, up 281.9% from FY2024.

  • Other Non-Current Assets carries a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
  • Going back by year, Other Non-Current Assets was $243,000 in FY2024 (-18.2%), $297,000 in FY2023 (+44.9%), $205,000 in FY2022 (-38.6%) and $334,000 in FY2021 (-37.2%).
  • The Q2 2026 figure represents the highest quarterly Other Non-Current Assets in data going back to Q4 2018.
  • Year-over-year, Other Non-Current Assets increased in two of the last seven quarters, with growth averaging 153.6%.
  • The fastest year-over-year change in Other Non-Current Assets over five years came in Q1 2026 (growth of 983.0%), and the weakest in Q2 2023 (a decline of 83.5%).
  • Business Quant data shows TRVI's Other Non-Current Assets at $2.61 million (Q1 2026), $928,000 (Q4 2025) and $103,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Trevi Therapeutics 2.04 Bn 2.04 Bn - 3.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.94 Mn
Mar 31, 2026 2.61 Mn
Dec 31, 2025 928,000.00
Sep 30, 2025 103,000.00
Jun 30, 2025 68,000.00
Mar 31, 2025 241,000.00
Dec 31, 2024 243,000.00
Sep 30, 2024 256,000.00
Jun 30, 2024 273,000.00
Mar 31, 2024 311,000.00
Dec 31, 2023 297,000.00
Sep 30, 2023 297,000.00
Jun 30, 2023 68,000.00
Mar 31, 2023 225,000.00
Dec 31, 2022 205,000.00
Sep 30, 2022 922,000.00
Jun 30, 2022 413,000.00
Mar 31, 2022 398,000.00
Dec 31, 2021 334,000.00
Sep 30, 2021 419,000.00
API Access

Trevi Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TRVI&period=max&api_key=YOUR_API_KEY